Long-acting Treatment and Prevention of HIV Are Here
Advances in long-acting treatment and prevention for HIV are changing the way we treat our patients.
Source: medscape.com
Page 24 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trials Network Today - Breaking & Trending Today
Evaluating the Validity and Reliability of the Gender Equitable Men's Scale Using a Longitudinal Cohort of Adolescent Girls and Young Women in South Africa
"Given the high vulnerability to HIV acquisition for the adolescent population, and the evidence linking gender norms to HIV acquisition and current and future programming designed to modify norms, it is important to understand the measurement properties of the GEMS instrument for this population."
Source: comminit.com
GSK : Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
For media and investors only Issued: London UK Primary vaccination with Beta-containing vaccine candidate delivers 64.7% efficacy against symptomatic... | June 24, 2022
Source: marketscreener.com
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Primary vaccination with Beta-containing vaccine candidate delivers 64.7% efficacy against symptomatic infection in adults, and 75.1% efficacy in participants previously infected with COVID-19 Against Omicron, sequencing analysis performed to date shows 72% efficacy in all adults and 93.2% in seropositives Favorable safety and tolerability profile
Source: pressreleasepoint.com
SU shines on 2022 TIME 100 list
Two scientists associated with Stellenbosch University (SU) have been selected for this year’s TIME 100 Most Influential People list.
Source: yiba.co.za